| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +1.97% | +2.53% | +52.73% | +156.66% | 1,037B | |
| +1.42% | +4.96% | +54.39% | +52.34% | 615B | |
| +1.43% | +5.25% | +37.31% | +78.74% | 448B | |
| +5.14% | +5.84% | +37.54% | +27.28% | 326B | |
| +1.85% | +4.64% | +38.53% | +39.87% | 293B | |
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | |
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | |
| +1.49% | +3.68% | +21.53% | +58.21% | 198B | |
| +0.40% | -0.64% | +18.78% | +62.28% | 162B | |
| Average | +0.69% | +1.12% | +28.77% | +50.10% | 395.27B | |
| Weighted average by Cap. | +0.43% | +1.47% | +38.33% | +75.23% |
Employees
4
Sector
Pharmaceuticals
